Waiting for the ‘yes’ from China | Tages-Anzeiger

“The Grasshoppers are about to be sold to the Chinese investment company Fosun – they can use it to secure their future. But is that really a good deal?”

Read the full article @ Tages-Anzeiger:

China three months after the outbreak – It is not over yet | Der Spiegel

“The Beijing leadership wants to slowly reopen the country. Where does it get confidence from?
Beijing is currently a confusing picture. There are first traffic jams on the five ring highways in the morning and evening, but during the day many streets are so empty that motorcyclists and sports car drivers compete in races.”

Read the full article @ Der Spiegel:

Private Swiss initiative to import medical goods from China | Swissinfo

“A private, “citizen” initiative organised by business groups in Geneva is to transport almost 100 tonnes of medical equipment into the country next week. More flights are set to follow.”

Read the full article @ Swissinfo:

China suspends entry by foreign nationals holding Chinese visas, residence permits | State Council of the People’s Republic of China

“China announced temporary suspension of entry by foreign nationals holding valid Chinese visas or residence permits on the night of March 26.
In view of the rapid spread of COVID-19 across the world, China has decided to temporarily suspend the entry into China by foreign nationals holding visas or residence permits still valid to the time of this announcement, effective from 0:00 am, March 28, 2020, said a statement jointly released by Chinese Foreign Ministry and the National Immigration Administration.”

Read the full article @ State Council of the People’s Republic of China:

Can China’s COVID-19 Statistics Be Trusted? | The Diplomat

“From GDP figures to coronavirus counts, China’s government has a long history of manipulating data for political gain.

As the number of COVID-19 cases rises in countries around the world, China continues to report a reduction in cases, with hundreds of patients “cured” and discharged from hospitals daily, according to information disseminated by the Ministry of Foreign Affairs. Leading Chinese epidemiologist Zhong Nanshan, who discussed the potential for a second wave of the virus, highlighted the success of the “intervention mechanism invented by China.” According to Zhong, “The core points are the ‘four earlys:’ early prevention, early detection, early diagnosis, and early quarantine.”

Read the full article @ The Diplomat:

Lianhua Qingwen effective in inhibiting coronavirus replication | CIIC

“Latest research shows that Traditional Chinese Medicine drug Lianhua Qingwen can significantly inhibit the replication of the novel coronavirus in cells infected with the virus, Beijing News reported. The results showed that it can significantly inhibit SARS-CoV-2 replication in Vero E6 cells and reduce inflammatory factors such as TNF-α, IL-6, CCL2 / MCP-1 and CXCL-10 / IP-10. In general, it could significantly inhibit the replication of the new coronavirus and counter inflammation. The results of the study, co-authored by well-known Chinese epidemiologist Zhong Nanshan and researcher Yang Zifeng from Guangzhou Medical University’s State Key Laboratory of Respiratory Diseases, have been published on Pharmacological Research.”

Read the full article @ China Internet Information Center (CIIC):

Il farmaco Roche testato in Ticino | RSI News

“COVID-19: è quello usato solitamente per curare l’artrite reumatoide; in Cina ha dato buoni risultati – L’intervista ad Alessandro Ceschi, direttore dell’istituto di scienze farmacologiche presso l’EOC.”

Interview | «Investitionskontrollen wären ein Schildbürgerstreich» | NZZ

“Stefan Brupbacher ist seit Januar 2019 CEO des Schweizer Verbandes der Maschinen-, Elektro- und Metallindustrie (Swissmem). Im Gastbeitrag plädiert der Jurist und Ökonom für Offenheit gegenüber chinesischen Investoren. Hiesige Firmen, so Brupbachers Fazit, profitierten von Eigentümern aus China.”

Lesen Sie den ganzen Artikel @ NZZ:

Interview | “Investment controls would be a foolish act” | NZZ

“Stefan Brupbacher has been CEO of the Swiss Association of the Mechanical, Electrical and Metal Industries (Swissmem) since January 2019. In this guest contribution, the lawyer and economist advocates openness to Chinese investors. Local companies, according to Brupbacher’s conclusion, would benefit from owners from China.

Read the full article @ NZZ:

Search for coronavirus vaccine turns spotlight on German biotech firms | Deutsche Welle

“”An der Goldgrube 12″ — literally translated “At the Goldmine 12” in English — is the postal address of German biotech firm Biontech in Mainz, Germany. The name is apt because the company could indeed strike it rich if it succeeds in its newest undertaking: finding a vaccine against coronavirus and the lung disease COVID-19 it causes.

So far, Biontech has been developing drugs against cancer, but a recent cash injection from Chinese drugmaker Fosun Pharma would allow it to speed up its efforts in the global race to find a vaccine against the novel pathogen, Biontech announced Monday (March 17). The Chinese offered €120 million ($133.3 million), some €44 million of the sum are in exchange for shares in Biontech.”

Read the full article @ Deutsche Welle:

The Roche drug tested in Ticino | RSI News

“COVID-19: the one usually used to treat rheumatoid arthritis; in China has given good results – The interview with Alessandro Ceschi, director of the institute of pharmacological sciences at the EOC.”

Read the full article @ RSI News:

Coronavirus: Swiss per capita infection rate surpasses China’s | Le News

“When countries are ranked based on infection rate (cases / population), Switzerland now ranks ahead of China. Only Italy, South Korea, Iran and Norway have higher per capita infection rates than Switzerland.”

Read the full article @ Le News:

Demiurge AI discovers the complete aetiology of COVID-19 and the Optimal Treatment Strategy for COVID-19 | finanzen.ch

“Demiurge is responding to the global outbreak of the 2019 novel coronavirus (COVID-19) through the appropriate use of our AI platform that can make accurate drug discoveries for diseases with limited available clinical data.”

Read the full article @ finanzen.ch:

China’s Huawei flies under the radar in Switzerland with industrial 5G networks for dairy farmers | SCMP

“A quiet Huawei Technologies-led 5G revolution is unfolding at the heart of Europe – in the bucolic Swiss hamlet of Taenikon. Far from President Donald Trump’s campaign to stop the world from using the Chinese company’s technology, cows in this northern Swiss village – with its whitewashed cottages and manicured fields – wear Huawei’s 5G-connected neck-straps instead of traditional flat bells.”

Read the full article @ SCMP:

Chinese economic disruption hits Swiss supply chains | SWI swissinfo.ch

“China’s sharp contraction in economic activity over the past month due to the coronavirus epidemic is sending shockwaves across the globe. Switzerland is one of the top ten countries exposed to Chinese supply disruptions, a United Nations report reveals.”

Read the full article @ Swissinfo:

Lights are on but no one’s working: How local governments are faking Coronavirus recovery | Caixin Global

“Local companies and officials are fraudulently boosting electricity consumption and other metrics in order to meet tough new back-to-work targets as the spread of Covid-19 in China wanes, a Caixin investigation has found.

As new coronavirus cases in China slowed in recent weeks, local governments in less-affected regions pushed companies and factories to return to work, typically by assigning concrete targets to district officials. Company insiders and local civil servants told Caixin that, under pressure to fulfill quotas they could not otherwise meet, they deftly cooked the books.

Leaving lights and air conditioners on all day long in empty offices, turning on manufacturing equipment, faking staff rosters and even coaching factory workers to lie to inspectors are just some of the ways they helped manufacture flashy statistics on the resumption of business for local governments to report up the chain.”

Read the full article @ Caixin Global:

La frontiera ai tempi del coronavirus | Corriere del Ticino

I ticinesi sembrano «autoconfinarsi» evitando di mettere piede in Lombardia – Perfino a Ponte Chiasso o a Ponte Tresa – «I clienti svizzeri hanno probabilmente paura, ma non ha molto senso visto che da loro entrano i frontalieri» – Ma anche a Chiasso la gente in giro è poca.

@ Corriere del Ticino | 4 marzo 2020

“The people of Ticino seem to “self-confine themselves” by avoiding setting foot in Lombardy – Even in Ponte Chiasso or Ponte Tresa – “Swiss customers are probably afraid, but it doesn’t make much sense since the frontier workers enter anyway in” – But also in Chiasso people are not going out.”